Can Tirzepatide Give You Diarrhoea?

Diarrhoea is a recognised common side effect of tirzepatide, most often tied to the adjustment period when starting or stepping up a dose.
Dehydration is the main practical risk: loose, frequent stools combined with reduced appetite can deplete fluids faster than you might notice.
Severe, persistent stomach pain reaching the back is a separate warning sign requiring urgent medical attention, distinct from typical GI upset.
You can report unexpected or serious side effects directly to the MHRA via the Yellow Card scheme, patients and carers can submit reports, not just healthcare professionals.

Yes, tirzepatide can cause diarrhoea. It is one of the more commonly reported gastrointestinal side effects, particularly in the first few weeks of treatment or after a dose increase. Most people find it mild and short-lived, though knowing what to expect — and when something warrants medical attention — makes a real difference. Tirzepatide is a prescription-only medicine, and a GPhC-registered prescriber will discuss your full side-effect profile as part of any consultation. The NHS medicines page for tirzepatide lists diarrhoea among the common side effects, defined as affecting up to 1 in 10 people.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How diarrhoea on tirzepatide typically unfolds, and what to do at each stage

Step 1: Why tirzepatide affects the gut in the first place

Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, which together slow how quickly food moves out of the stomach. That slowing is partly responsible for the appetite reduction that makes the medicine effective. The downside is that the gut takes time to adjust. During that window, motility can become unpredictable in both directions: some people experience constipation, others diarrhoea, and some alternate between the two.

Loose stools tend to cluster around the first two to four weeks after starting treatment and, again, after each dose step. That pattern is worth knowing because it helps you distinguish the ordinary adjustment period from something that needs a prescriber's input. Our overview of Mounjaro side effects covers the broader GI picture if you want the full list.

Fatty, fried or very rich meals can make GI symptoms noticeably worse. If you are wondering whether tirzepatide can cause diarrhea and what tends to trigger it, a quick habit worth forming is to check what you ate in the 24 hours before a bad day, as many people spot a reliable pattern within a week or two, which gives them something practical to adjust.

Step 2: Managing loose stools day to day

The most important practical priority is hydration. Diarrhoea that comes alongside reduced appetite is a combination that can leave you short on fluids without feeling particularly thirsty. Small, frequent sips of water across the day tend to work better than catching up in one go. Oral rehydration sachets are a reasonable option if stools are very loose for more than a day.

Diet adjustments matter too. Smaller portions, lower-fat meals and enough dietary fibre (without overdoing insoluble roughage during a flare) help the gut settle more quickly. Protein is worth protecting, appetite suppression can lead people to under-eat it, which compounds fatigue. If you want specifics on eating alongside treatment, the weight-loss treatment overview covers the lifestyle side of things.

Most people find symptoms ease significantly by weeks three to six, without any change to their dose. Slowing a dose increase by a few weeks (if clinically appropriate) is something a prescriber can discuss; it is not something to decide unilaterally. For broader detail on how tirzepatide and diarrhea relate within the wider side-effect picture, the tirzepatide diarrhoea side-effect page goes deeper.

Step 3: When to get medical help

Ordinary adjustment-period diarrhoea is uncomfortable but not dangerous for most people. There are situations, however, where prompt medical contact is the right call.

Contact your GP or prescriber if: diarrhoea is severe, lasts more than two to three days without improvement, or is causing signs of dehydration (dizziness when standing, very dark urine, persistent dry mouth). If you are unsure whether Mounjaro is giving you diarrhea or whether something else is to blame, children and older adults dehydrate faster, so the threshold for seeking help is lower.

Go to A&E or call 999 if you develop severe, persistent stomach pain, particularly pain that reaches into the back, with or without vomiting. This symptom pattern can indicate acute pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines as a known but infrequent serious side effect. It is not the same as typical GI discomfort and should not be managed at home.

Allergic reactions (throat tightening, severe skin rash, difficulty breathing) also require emergency attention. If something feels wrong in a way that is hard to describe, calling 111 is a sensible first step. You can also report any unexpected side effect through the Yellow Card scheme; those reports genuinely inform MHRA monitoring.

Step 4: What this means for your treatment going forward

Persistent GI side effects are one of the more common reasons people pause or stop tirzepatide early, which is a shame when the symptoms are manageable with the right support. A prescriber's job, at every review, is partly to distinguish the ordinary adjustment curve from a pattern that suggests the medicine is not well tolerated at a given dose.

At nume, a real clinician reviews your case before every repeat order, not a checklist running automatically. If diarrhoea is affecting your quality of life, that is precisely the kind of thing to raise in that review. Our clinical team regularly fields questions about GI side effects, it is among the most common topics. The FAQs page also covers questions we hear most often about tolerance and dose timing.

If you are still weighing whether tirzepatide (sold in the UK as Mounjaro) is right for you, the Mounjaro overview sets out the full picture. And if you are ready to have the conversation with a prescriber, checking your eligibility takes a few minutes with no commitment.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions